Medical News

RSS

Obesity rate decreases as amount of weekly LTPA increases

It may seem intuitive that greater amounts of exercise lead to less obesity, but an Indiana University study has found that this conventional wisdom applies primarily to white women. The findings draw attention not only to racial, ethnic and gender differences regarding exercise but also to the role work can play.

21 May 2010

Positive results from Phase 1 study evaluating IV administration of JX-594 to metastatic cancer patients

Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today reported positive results from its Phase 1 dose escalation study evaluating the intravenous administration of JX-594 to patients with metastatic cancer. The data presented today demonstrated clear dose-related delivery to solid tumors, cancer-targeted replication and gene expression, and anti-cancer effects of JX-594 delivered IV.

21 May 2010

JCVI researchers construct first self-replicating, synthetic bacterial cell

Researchers at the J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, published results today describing the successful construction of the first self-replicating, synthetic bacterial cell. The team synthesized the 1.08 million base pair chromosome of a modified Mycoplasma mycoides genome.

21 May 2010

Hepatitis C affects so many people and yet not recognized as serious public health problem

May is Hepatitis Awareness Month, and you may find it surprising to learn an estimated 4 million Americans have been infected with Hepatitis C. This silent disease is three to five times more prevalent than HIV. Hepatitis C is the most common cause of liver transplants in the U.S.

21 May 2010

HemaCare announces commercial cell therapy collection agreement with Dendreon

HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.

21 May 2010

Experts to discuss impacts of air pollution on life expectancy, cardiovascular disease

The U.S. Environmental Protection Agency is sponsoring a seminar called "Breathe Cleaner, Live Longer: Understanding Air Pollution after 40 Years." The event is co-sponsored by the American Heart Association and the U.S. House of Representatives Committee on Science and Technology.

21 May 2010

Toxcure granted U.S. patent for method of treating neoplasms with neurotoxins

Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.

21 May 2010

Data from Phase 3 clinical trials of PROVENGE in advanced prostate cancer to be presented at ASCO 2010

Dendreon Corporation today announced the upcoming presentation of data from integrated analyses of three Phase 3 PROVENGE (sipuleucel-T) clinical trials of an autologous cellular immunotherapy in advanced prostate cancer, to be presented at the annual meeting of the American Society of Clinical Oncology in Chicago on Monday, June 7 at 8:00 a.m. CT.

21 May 2010

Caregivers can give complete clinical picture of brain cancer patients' condition

Despite grim prognoses and aggressive treatments, cancer patients suffering from malignant gliomas -- primary brain tumors -- often rate their quality of life more optimistically than their caregivers do, according to a new Northwestern University Feinberg School of Medicine study.

21 May 2010

SLU Hospital announces increase in number of minimally-invasive spinal procedures performed

With the recent launch of the Neurosurgical Spine Program at Saint Louis University Hospital's Center for Cerebrovascular and Skull Base Surgery, the hospital has seen a dramatic increase in the number of minimally-invasive spinal procedures, including lumbar spinal fusion surgery. Designed to stop the motion at a painful vertebral segment, this procedure is traditionally performed via a large incision on the back, stripping vital muscles away from the spine. However, the emergence of minimally-invasive neurosurgical techniques is revolutionizing spinal surgery.

21 May 2010

Preliminary data of BIBW 2992 in head and neck cancer, NSCLC to be presented at ASCO 2010

Boehringer Ingelheim will announce preliminary data in the areas of head and neck cancer and non-small cell lung cancer for one of the company's investigational compounds, BIBW 2992. These data will be presented at the 2010 Annual Meeting of the American Society of Clinical Oncology annual meeting in Chicago.

21 May 2010

Medtronic announces clinical data presentations on cardiovascular devices at EuroPCR

Medtronic, Inc., announced today the schedule of important clinical data presentations during EuroPCR, a major cardiology meeting taking place May 25-28 in Paris at the Palais de Congrès.

21 May 2010

Onyx Pharmaceuticals announces presentations evaluating carfilzomib for multiple myeloma at 46th ASCO

Onyx Pharmaceuticals, Inc. today announced the presentation of several studies evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8, 2010 in Chicago, IL.

21 May 2010

Blood clot-related strokes decrease among whites for the first time: Study

The incidence of blood clot-related strokes fell among whites in the Greater Cincinnati/Northern Kentucky area for the first time, according to long-term surveillance study representative of strokes in blacks and whites nationwide reported in Stroke: Journal of the American Heart Association.

21 May 2010

African 'green revolution' should focus on small farmers, U.N. report says

Investments in agricultural technology should be directed to Africa's smallholder farmers in an effort to increase food security after decades of low funding, the U.N. Conference on Trade and Development (UNCTAD) said in a report on Wednesday, Reuters reports (Lynn, 5/19).

21 May 2010

Strata Health Solutions, Medworxx announce partnership agreement

Strata Health Solutions Inc. a leader in delivery of patient flow technology to global health organizations and Medworxx Inc., provider of healthcare solutions for patient flow, compliance and education announced today a partnership agreement that will provide a full view of the patient flow cycle, both inside and outside of the hospital.

21 May 2010

Abbott to acquire Piramal's Healthcare Solutions business

Abbott announced a definitive agreement with Piramal Healthcare Limited to acquire full ownership of Piramal's Healthcare Solutions business (Domestic Formulations), a leader in the Indian branded generics market, for an up-front payment of $2.12 billion, plus $400 million annually for the next four years, giving Abbott the No. 1 position in the Indian pharmaceutical market.

21 May 2010

Long-term data demonstrates clinical benefits of Exelixis XL184 for medullary thyroid cancer

Exelixis, Inc. today reported long-term results in a cohort of 37 medullary thyroid cancer (MTC) patients who participated in the phase 1 study of XL184. Dr. Razelle Kurzrock from the MD Anderson Cancer Center in Houston, TX will present the data in a Clinical Science Symposium (Abstract #5502) on Monday, June 7 at 10:15 AM at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago.

21 May 2010

Media examines recent Oxfam report on impact of aid to developing countries

In a recent report, Oxfam "outlines how aid has contributed to economic growth in poor countries by getting 33 million more children into school, boosting access to HIV drugs tenfold, funding tens of millions of anti-malaria bed nets, and building up health services," Reuters AlertNet reports (Rowling, 5/20).

21 May 2010

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

British Columbia is leading the way in vaccinations to protect children from serious disease. The province is the first in Canada to include Prevnar 13, the vaccine that provides the broadest coverage available against Streptococcus pneumoniae that may cause invasive pneumococcal disease, in the routine child immunization program.

21 May 2010

Medical News

Obesity rate decreases as amount of weekly LTPA increases

Positive results from Phase 1 study evaluating IV administration of JX-594 to metastatic cancer patients

JCVI researchers construct first self-replicating, synthetic bacterial cell

Hepatitis C affects so many people and yet not recognized as serious public health problem

HemaCare announces commercial cell therapy collection agreement with Dendreon

Experts to discuss impacts of air pollution on life expectancy, cardiovascular disease

Toxcure granted U.S. patent for method of treating neoplasms with neurotoxins

Data from Phase 3 clinical trials of PROVENGE in advanced prostate cancer to be presented at ASCO 2010

Caregivers can give complete clinical picture of brain cancer patients' condition

SLU Hospital announces increase in number of minimally-invasive spinal procedures performed

Preliminary data of BIBW 2992 in head and neck cancer, NSCLC to be presented at ASCO 2010

Medtronic announces clinical data presentations on cardiovascular devices at EuroPCR

Onyx Pharmaceuticals announces presentations evaluating carfilzomib for multiple myeloma at 46th ASCO

Blood clot-related strokes decrease among whites for the first time: Study

African 'green revolution' should focus on small farmers, U.N. report says

Strata Health Solutions, Medworxx announce partnership agreement

Abbott to acquire Piramal's Healthcare Solutions business

Long-term data demonstrates clinical benefits of Exelixis XL184 for medullary thyroid cancer

Media examines recent Oxfam report on impact of aid to developing countries

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News